Abstract
CCPMs have shown great potential in preclinical models and even clinical evaluation,
with there being a continued need for the development of orthogonal linker chemistries
for the crosslinking and triggered release of API cargos, also with increasing API
complexity. The aim of this thesis was to expand the toolbox available to this regard:
• Implement NCL as a crosslinking tool to obtain CCPMs using two different, well
described thermosensitive diblock copolymer systems, namely mPEG-PNIPAM and
mPEG-pHPMAmLacn.
• Study the crosslinking efficiency and stability of CCPMs formed by two different
crosslinking approaches, either by using a small molecule crosslinker or with crossreactive
complementary polymers.
• Demonstrate improved compatibility of fragile compounds (therapeutic and
diagnostic) with CCPMs using NCL as a crosslinking reaction.
15
• Assess the state of the art for the use of AuNCs in biomedical applications in
diagnostic, therapeutic and theranostic capacity.
• Develop linking technologies, using light induced (AuNC based) and reduction
sensitive (disulfide based) release triggers for the release of APIs.
• Apply reduction sensitive release linker technology to promising but challenging
API classes, namely therapeutic peptides and siRNA, with entrapment in CCPMs.
• Keeping an eye on industrial applicability
with there being a continued need for the development of orthogonal linker chemistries
for the crosslinking and triggered release of API cargos, also with increasing API
complexity. The aim of this thesis was to expand the toolbox available to this regard:
• Implement NCL as a crosslinking tool to obtain CCPMs using two different, well
described thermosensitive diblock copolymer systems, namely mPEG-PNIPAM and
mPEG-pHPMAmLacn.
• Study the crosslinking efficiency and stability of CCPMs formed by two different
crosslinking approaches, either by using a small molecule crosslinker or with crossreactive
complementary polymers.
• Demonstrate improved compatibility of fragile compounds (therapeutic and
diagnostic) with CCPMs using NCL as a crosslinking reaction.
15
• Assess the state of the art for the use of AuNCs in biomedical applications in
diagnostic, therapeutic and theranostic capacity.
• Develop linking technologies, using light induced (AuNC based) and reduction
sensitive (disulfide based) release triggers for the release of APIs.
• Apply reduction sensitive release linker technology to promising but challenging
API classes, namely therapeutic peptides and siRNA, with entrapment in CCPMs.
• Keeping an eye on industrial applicability
Original language | English |
---|---|
Awarding Institution |
|
Supervisors/Advisors |
|
Award date | 15 Apr 2024 |
Publisher | |
Print ISBNs | 978-94-6483-943-2 |
DOIs | |
Publication status | Published - 15 Apr 2024 |
Keywords
- Core-crosslinked polymeric micelles
- native chemical ligation
- linkers
- gold nanoclusters
- drug delivery
- click chemistry
- disulfide
- peptides